| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A familiar species of Crank: Anti-Vaccinationists in medical history
|
Janssen, Diederik F.
|
|
|
40 |
31 |
p. 4135-4141
|
article
|
| 2 |
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines
|
Smith, William J.
|
|
|
40 |
31 |
p. 4182-4189
|
article
|
| 3 |
Antibody dependent cell cytotoxicity is maintained by the unmutated common ancestor of 6F5, a Gp41 conformational epitope targeting antibody that utilizes heavy chain VH1-2
|
Wrotniak, Brian H.
|
|
|
40 |
31 |
p. 4174-4181
|
article
|
| 4 |
A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study
|
Psihogios, Athanasios
|
|
|
40 |
31 |
p. 4065-4080
|
article
|
| 5 |
Corrigendum to “Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States” [Vaccine 40(7) (2022) 1001–1009]
|
Malter, Kyle B.
|
|
|
40 |
31 |
p. 4281
|
article
|
| 6 |
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery
|
Toor, Jaspreet
|
|
|
40 |
31 |
p. 4142-4149
|
article
|
| 7 |
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice
|
Zhao, Fu-jie
|
|
|
40 |
31 |
p. 4211-4219
|
article
|
| 8 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
31 |
p. IFC
|
article
|
| 9 |
Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs
|
Halme, Jussi
|
|
|
40 |
31 |
p. 4242-4252
|
article
|
| 10 |
Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study
|
Lightowler, Maria S.
|
|
|
40 |
31 |
p. 4199-4210
|
article
|
| 11 |
Effects of N-acylation on the immune adjuvanticity of analogs of the Quillaja saponins derivative GPI-0100
|
Marciani, Dante J.
|
|
|
40 |
31 |
p. 4169-4173
|
article
|
| 12 |
Estimating the burden of adult hospitalized RSV infection including special populations
|
Nowalk, Mary Patricia
|
|
|
40 |
31 |
p. 4121-4127
|
article
|
| 13 |
Evaluation of prime and prime-boost immunization strategies in BALB/c mice inoculated with Leishmania infantum transfected with toxic plasmids
|
Augusto Sanches Roque, Guilherme
|
|
|
40 |
31 |
p. 4105-4115
|
article
|
| 14 |
Excluding numeric side-effect information produces lower vaccine intentions
|
Shoots-Reinhard, Brittany
|
|
|
40 |
31 |
p. 4262-4269
|
article
|
| 15 |
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries
|
Leigh, Jeanna Parsons
|
|
|
40 |
31 |
p. 4081-4089
|
article
|
| 16 |
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
|
Hashimoto, Masayuki
|
|
|
40 |
31 |
p. 4231-4241
|
article
|
| 17 |
Influenza cases in nine aged care facilities in Sydney, Australia over a three-year surveillance period, 2018—2020
|
Kunasekaran, Mohana Priya
|
|
|
40 |
31 |
p. 4253-4261
|
article
|
| 18 |
Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings
|
Bilgin, Gizem M.
|
|
|
40 |
31 |
p. 4128-4134
|
article
|
| 19 |
Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection
|
Schneider, Cosette G.
|
|
|
40 |
31 |
p. 4270-4280
|
article
|
| 20 |
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years
|
Chichili, Gurunadh R.
|
|
|
40 |
31 |
p. 4190-4198
|
article
|
| 21 |
Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis
|
Slarve, Matthew
|
|
|
40 |
31 |
p. 4160-4168
|
article
|
| 22 |
Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study
|
Patel, Kavin M.
|
|
|
40 |
31 |
p. 4098-4104
|
article
|
| 23 |
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
|
Eugenia-Toledo-Romaní, María
|
|
|
40 |
31 |
p. 4220-4230
|
article
|
| 24 |
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-β-cyclodextrin: A phase 1 clinical trial
|
Watanabe, Akane
|
|
|
40 |
31 |
p. 4150-4159
|
article
|
| 25 |
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system
|
Woo, Emily Jane
|
|
|
40 |
31 |
p. 4116-4120
|
article
|
| 26 |
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
|
Salmanton-García, Jon
|
|
|
40 |
31 |
p. 4090-4097
|
article
|
Journal description